EMEA-001893-PIP01-15-M02
Key facts
| Active substance |
Naldemedine
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0379/2021
|
| PIP number |
EMEA-001893-PIP01-15-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of opioid-induced constipation (OIC)
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Shionogi Limited
E-mail: shionogiclintrials-admin@shionogi.co.jp |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|